Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|August 22, 2012
Design and production of multimeric antibody fragments, focused on diabodies with enhanced clinical efficacyGlenn A Powers, Peter J Hudson, Michael P Wheatcroft
Chemistry & Biology|September 5, 2003
The structure of docking domains in modular polyketide synthasesR William Broadhurst, Daniel Nietlispach, Michael P Wheatcroft, et al.
EJNMMI Radiopharmacy and Chemistry|May 8, 2024
Automated synthesis of [89Zr]ZrCl4, [89Zr]ZrDFOSquaramide-bisPh(PSMA) and [89Zr]ZrDFOSquaramide-TATEAsif Noor, Peter D Roselt, Emily R McGowan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 11, 2015
Diabody Pretargeting with Click Chemistry In VivoSander M J van Duijnhoven, Raffaella Rossin, Sandra M van den Bosch, et al.
EJNMMI Radiopharmacy and Chemistry|November 26, 2024
Preclinical evaluation and automated synthesis of [89Zr]ZrDFOSquaramide-girentuximab for diagnostic imaging of carbonic anhydrase IX positive tumoursAsif Noor, Emily R McGowan, Jessica K Van Zuylekom, et al.
Molecular Pharmaceutics|January 26, 2026
Synthesis and Evaluation of D8W, an Octadentate Desferrioxamine Analogue with Enhanced Water Solubility Designed for 89Zr-ImmunoPET ImagingJames L Wood, Saikat Ghosh, Callum A Rosser, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 15, 2026
Predicting tumour and organ dose in α-radiopharmaceutical therapy: a 89Zr-based dosimetric approach for 225AcRobin I J Merkx, Simone C Kleinendorst, Mark Rijpkema, et al.
Pharmaceuticals (Basel, Switzerland)|May 28, 2022
Carbonic Anhydrase IX-Targeted α-Radionuclide Therapy with 225Ac Inhibits Tumor Growth in a Renal Cell Carcinoma ModelRobin I J Merkx, Mark Rijpkema, Gerben M Franssen, et al.
Journal of Medicinal Chemistry|August 14, 2020
Bivalent Inhibitors of Prostate-Specific Membrane Antigen Conjugated to Desferrioxamine B Squaramide Labeled with Zirconium-89 or Gallium-68 for Diagnostic Imaging of Prostate CancerAsif Noor, Jessica K Van Zuylekom, Stacey E Rudd, et al.
Chemical Science|August 2, 2024
A first-in-class dual-chelator theranostic agent designed for use with imaging-therapy radiometal pairs of different elementsJames L Wood, Saikat Ghosh, Zachary H Houston, et al.
Pageof 2